These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34838793)

  • 21. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
    Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
    BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erysipelothrix rhusiopathiae and Mycoplasma hyopneumoniae: the sensitivities of enzyme-linked immunosorbent assays for detecting vaccinated sows of unknown disease status using serum and colostrum, and the correlation of the results for sow serum, colostrum, and piglet serum.
    Jenvey CJ; Reichel MP; Cockcroft PD
    J Vet Diagn Invest; 2015 Mar; 27(2):211-6. PubMed ID: 25613041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of swine antigen-specific antibody responses to Mycoplasma hyopneumoniae infection determined by protein microarray.
    Petersen AC; Clampitt JM; Minion FC
    Vet Microbiol; 2019 Mar; 230():195-201. PubMed ID: 30827388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological cross-reactivity of porcine reference antisera to Mycoplasma hyopneumoniae, M. flocculare, M. hyorhinis and M. hyosynoviae indicated by the enzyme-linked immunosorbent assay, complement fixation and indirect hemagglutination tests.
    Freeman MJ; Armstrong CH; Sands-Freeman LL; Lopez-Osuna M
    Can J Comp Med; 1984 Apr; 48(2):202-7. PubMed ID: 6372971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of Commercial Mycoplasma hyopneumoniae Serum Enzyme-Linked Immunosorbent Assays under Experimental and Field Conditions.
    Poeta Silva APS; Magtoto RL; Souza Almeida HM; McDaniel A; Magtoto PD; Derscheid RJ; Merodio MM; Matias Ferreyra FS; Gatto IRH; Baum DH; Clavijo MJ; Arruda BL; Zimmerman JJ; Giménez-Lirola LG
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32967897
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of the in vitro growing dynamics and kinetics of the non-pathogenic J and pathogenic 11 and 232 Mycoplasma hyopneumoniae strains.
    Garcia-Morante B; Dors A; León-Kempis R; Pérez de Rozas A; Segalés J; Sibila M
    Vet Res; 2018 May; 49(1):45. PubMed ID: 29801517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental evaluation of
    Kim S; Oh T; Yang S; Cho H; Chae C
    Can J Vet Res; 2021 Jan; 85(1):77-81. PubMed ID: 33390658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
    Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
    Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.
    Wang Y; Wang J; Zhou M; Liu P; Zhang E; Li Y; Lin J; Feng Z; Yang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31492763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of piglets up to 1 week of age with a single-dose Mycoplasma hyopneumoniae vaccine induces protective immunity within 2 weeks against virulent challenge in the presence of maternally derived antibodies.
    Wilson S; Van Brussel L; Saunders G; Runnels P; Taylor L; Fredrickson D; Salt J
    Clin Vaccine Immunol; 2013 May; 20(5):720-4. PubMed ID: 23486417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a highly immunogenic Mycoplasma hyopneumoniae lipoprotein Mhp366 identified by peptide-spot array.
    Meens J; Bolotin V; Frank R; Böhmer J; Gerlach GF
    Vet Microbiol; 2010 May; 142(3-4):293-302. PubMed ID: 19913364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
    Moreau IA; Miller GY; Bahnson PB
    Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination inhibits TLR2 transcription via suppression of GR nuclear translocation and binding to TLR2 promoter in porcine lung infected with Mycoplasma hyopneumoniae.
    Sun Z; Liu M; Zou H; Li X; Shao G; Zhao R
    Vet Microbiol; 2013 Dec; 167(3-4):425-33. PubMed ID: 24035265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
    Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
    Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
    Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
    Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systems Immunology Characterization of Novel Vaccine Formulations for
    Matthijs AMF; Auray G; Jakob V; García-Nicolás O; Braun RO; Keller I; Bruggman R; Devriendt B; Boyen F; Guzman CA; Michiels A; Haesebrouck F; Collin N; Barnier-Quer C; Maes D; Summerfield A
    Front Immunol; 2019; 10():1087. PubMed ID: 31178860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal assessment of two Mycoplasma hyopneumoniae enzyme-linked immunosorbent assays in challenged and contact-exposed pigs.
    Fano E; Pijoan C; Dee S; Deen J
    J Vet Diagn Invest; 2012 Mar; 24(2):383-7. PubMed ID: 22379055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
    Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
    Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival analysis of two Mycoplasma hyopneumoniae eradication methods.
    Yeske P; Valeris-Chacin R; Singer RS; Pieters M
    Prev Vet Med; 2020 Jan; 174():104811. PubMed ID: 31710945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.